CytRx Corp. buy tbackenh
Start price
19.05.17
/
50%
€2.81
Target price
02.06.17
€6.49
Performance (%)
53.03%
End price
02.06.17
€4.30
Summary
This prediction ended on 02.06.17 with a price of €4.30. With a performance of 53.03% the BUY prediction by tbackenh was a big success. tbackenh has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| CytRx Corp. | - | - | - | - |
| iShares Core DAX® | 3.002% | 4.755% | 23.700% | 68.627% |
| iShares Nasdaq 100 | 2.966% | 0.363% | 8.027% | 116.238% |
| iShares Nikkei 225® | 5.606% | 4.528% | 20.313% | 56.217% |
| iShares S&P 500 | 2.312% | 1.811% | 5.451% | 70.924% |
Comments by tbackenh for this prediction
In the thread CytRx Corp. diskutieren
CytRx Corp.
Interessant wird die Veröffentlichung der Phase-3-Studie in Q3. Ein positives Ergebnis könnte Rüclenwind bedeuten.
(Stop Loss Kurs erreicht)


